Nuzenio

Tradingview Zvra

Tradingview Zvra entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 13 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Zebra Technologies Corporation Stock 12‑Month Price Target Raised to $410.14, Implies 13% Upside - TradingViewTradingView · Fri, 07 Aug 2026 13:20:26 GMTZevra Therapeutics, Inc. Stock 12‑Month Price Target Raised to $25.11, Implies 138% Upside - TradingViewTradingView · Thu, 06 Aug 2026 11:20:20 GMTZVRA: Q2 revenue up 53% to $39.7M, driven by MIPLYFFA growth and robust cash position of $260.2M - TradingViewTradingView · Wed, 05 Aug 2026 22:46:54 GMTZevra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 22:21:28 GMTZEVRA THERAPEUTICS, INC. 2026: Revenue $39.66M, EPS $0.14— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:21:01 GMTZVRA: Revenue growth and strong liquidity support ongoing rare disease pipeline advancement - TradingViewTradingView · Wed, 05 Aug 2026 21:20:16 GMTZevra Therapeutics Q2 revenue rises 53% on MIPLYFFA sales - TradingViewTradingView · Wed, 05 Aug 2026 21:10:32 GMTZevra Reports Q2 2026: $39.7M Revenue, $8.8M Net Income, $260.2M Cash - TradingViewTradingView · Wed, 05 Aug 2026 20:47:58 GMT

Timeline

Fri, 07 Aug 2026 13:20:26 GMTZebra Technologies Corporation Stock 12‑Month Price Target Raised to $410.14, Implies 13% Upside - TradingView
Thu, 06 Aug 2026 11:20:20 GMTZevra Therapeutics, Inc. Stock 12‑Month Price Target Raised to $25.11, Implies 138% Upside - TradingView
Wed, 05 Aug 2026 22:46:54 GMTZVRA: Q2 revenue up 53% to $39.7M, driven by MIPLYFFA growth and robust cash position of $260.2M - TradingView
Wed, 05 Aug 2026 22:21:28 GMTZevra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Wed, 05 Aug 2026 21:21:01 GMTZEVRA THERAPEUTICS, INC. 2026: Revenue $39.66M, EPS $0.14— 10-Q Summary - TradingView
Wed, 05 Aug 2026 21:20:16 GMTZVRA: Revenue growth and strong liquidity support ongoing rare disease pipeline advancement - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Zvra.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.